Axsome Therapeutics (AXSM) with a notable insider buy on 6-25 from Director Mark Coleman of $374,280 in stock at $23.10. AXSM has seen buys from the CFO and another director this year from $20.80 to $23 with over $400,000 in stock accumulated since M...